Liposomal apigenin 500mg Softgels - Optimal Apigenin Supplement with Fisetin, Quercetin and Theaflavins - 12 Month Supply
- Liposomes Are Liquid Fortresses That Optimize Absorption | Liposomes are microscopic liquid spheres that envelop apigenin, protecting it and enhancing its absorption. Our proprietary formula uses 100 mg of non-GMO sunflower phospholipids which allows for natural liposome formation and optimal absorption of 500mg apigenin into the circulation.
- Stress, Mood and Sleep | Get this natural apigenin supplement and wake up feeling refreshed and renewed.
- Backed by the Senolytics Blend | Combined with fisetin, quercetin and theaflavins, this ‘senolytic’ formulation is specially designed to to give the best result.
- The Perfect Way to Support the Day | Don't starve for change. Start to change with 1 softgel of Cenffitio liposomal apigenin as part of your daily regime.
Pomembne informacije
Sestavine
Proprietary Liposomal Apigenin Blend, Fisetin, Quercetin, Theaflavins
Navodila
For adults. As a dietary supplement, take one (1) softgel daily with water, or as directed by your healthcare professional.
Pravna odpoved
Izjave o prehranskih dopolnilih FDA ni ocenila in niso namenjene diagnosticiranju, zdravljenju, zdravljenju ali preprečevanju katere koli bolezni ali zdravstvenega stanja.
Dimenzije proizvodov
6.85 x 4.57 x 3.98 inches; 1.68 Pounds
Specifikacije
| Sestavine | Quercetin, Fisetin, Lastniška liposomska mešanica apigenina, Teaflavini |
| Blagovna znamka | Cenffitio |
| Datum izteka veljavnosti | Nov 2027 |
| aroma | Quercetin |
| Število enot | 360.00 Število |
| Obrazec predmeta | Softgel |
| Starostni razpon (opis) | Odrasli |
| Število postavk | 6 |
| Način odmerjanja | Gel |
| Oblika | Steklenica |
| Dimenzije predmeta L X W X H | 6.85 X 4.57 X 3.98 Palci |
| Materialna značilnost | Brez Gmo |
| Vrsta izdelka | Prehransko dopolnilo |
| Tags | |
|---|---|
| Tags | |
Tukaj bo prikazan vaš dinamični izsek...
To sporočilo se prikaže, ker niste navedli filtra in predloge, ki ju želite uporabiti.









